VHL is a well-known tumour suppressor gene and VHL disease is characterised by a distinct subset of highly vascular tumours, notably renal carcinoma, angiomas, and hemangioblastomas (Kaelin, 2007). The gene discussed is VHL; the disease is neoplasm.